New Year Bumper Sale @ Rs. 1 X
Tagon M is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Tagon M safe for pregnant women?
Pregnant women may experience moderate side effects from Tagon M. It is best to stop taking Tagon M immediately and inform your doctor if you notice any discomfort.
Is the use of Tagon M safe during breastfeeding?
Taking Tagon M may lead to serious side effects if you are breastfeeding. Tagon M should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Tagon M on the Kidneys?
Information about safety of Tagon M for kidney is not available since scientific research on this topic is yet to be done.
What is the effect of Tagon M on the Liver?
There is no research available on the side effects of Tagon M on the liver. Therefore, its impact is unknown.
What is the effect of Tagon M on the Heart?
Information about safety of Tagon M for heart is not available since scientific research on this is yet to be done.
Tagon M should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tagon M unless your doctor advises you to do so -
Is this Tagon M habit forming or addictive?
No, you will not get addicted to Tagon M.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Tagon M since it does not cause drowsiness.
Is it safe?
Tagon M is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Tagon M is not used to treat mental disorders.
Interaction between Food and Tagon M
Due to a lack of research, nothing can be said about the consequences of taking Tagon M together with food.
Interaction between Alcohol and Tagon M
Information about the interaction of Tagon M and alcohol is not currently available because this topic has not been researched yet.
Yes, Tagon M can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Tagon M causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Tagon M may need to be adjusted.
Yes, Tagon M can cause some sleep problems, especially insomnia. On the other hand, Tagon M has proven to be useful for preventing sleep apnea. The exact relationship between Tagon M and sleep problems is still not clear, and further studies are needed for a clearer understanding.
Tagon M is not a known cause of alopecia (hair loss). However, the conditions treated by Tagon M type 2 diabetes and PCOS, often list hair loss as a possible symptom.
Yes, Tagon M commonly cause stomach upset like diarrhea, abdominal pain, nausea, and vomiting. To avoid these side effects you should take Tagon M with your meal and increase the dose gradually.
Tagon M is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826